English
Home > Products > CAS NO 2921-57-5

China CAS NO 2921-57-5 Factory

abide by the contract, conforms into the market requirement, joins in the market competition by its good quality also as provides a lot more comprehensive and great company for purchasers to let them turn into huge winner. The pursue from the firm, would be the clients' gratification for CAS NO 2921-57-5,2921-57-5,Methylprednisolone API,Methylprednisolone hemisuccinate, Our firm is functioning with the procedure principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we could have a pleasant romantic relationship with businessman from all around the environment.
CAS NO 2921-57-5, Our continual availability of high grade products in combination with our excellent pre-sale and after-sales service ensures strong competitiveness in an increasingly globalized market. welcome new and old customers from all walks of life to contact us for future business relationships and mutual success!

Related Products

Hot Products

  • Citric acid monohydrate

    Citric acid monohydrate

    Product Name:Citric acid monohydrate
    Molecular Formula:C6H10O8
    Molecular Weight:210.1388
    CAS Registry Number:5949-29-1
  • Entecavir

    Entecavir

    Product Name:Entecavir
    Molecular Formula:C12H15N5O3
    Molecular Weight;277.28
    CAS Registry Number;142217-69-4
  • 2-(Methylamino)pyridine-3-methanol

    2-(Methylamino)pyridine-3-methanol

    Product Name:2-(Methylamino)pyridine-3-methanol
    Molecular Formula:C7H10N2O
    Molecular Weight:138.17
    CAS Registry Number:32399-12-5
  • Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate

    Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate

    Product Name:Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate
    Molecular Formula:C12H20N2O3
    Molecular Weight:240.3
    CAS Registry Number:144689-93-0
  • Carfilzomib

    Carfilzomib

    Product Name:Carfilzomib
    Molecular Formula:C40H57N5O7
    Molecular Weight;719.92
    CAS Registry Number;868540-17-4
  • 2,6-Dichlorofluorobenzene

    2,6-Dichlorofluorobenzene

    Product Name:2,6-Dichlorofluorobenzene
    Molecular Formula:C6H3Cl2F
    Molecular Weight:164.99
    CAS Registry Number:2268-05-5
  • Related Blog
  • Reviews

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept